Chemical Compound Review:
Bucindolol 2-[2-hydroxy-3-[[1-(1H-indol- 3-yl)-2...
Synonyms:
Bucindololum, SureCN20138, CHEMBL321582, AG-G-78346, CHEBI:259883, ...
Liggett,
Mialet-Perez,
Thaneemit-Chen,
Weber,
Greene,
Hodne,
Nelson,
Morrison,
Domanski,
Wagoner,
Abraham,
Anderson,
Carlquist,
Krause-Steinrauf,
Lazzeroni,
Port,
Lavori,
Bristow,
Torp-Pedersen,
Køber,
Ball,
Hall,
Brendorp,
Ottesen,
Berning,
Jensen,
Hampton,
Zilles,
Eberle,
Carlsen,
Willette,
Aiyar,
Yue,
Mitchell,
Disa,
Storer,
Naselsky,
Stadel,
Ohlstein,
Ruffolo,
Watts,
Fink,
Silver,
Cushing,
- Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol. Eichhorn, E.J., Bedotto, J.B., Malloy, C.R., Hatfield, B.A., Deitchman, D., Brown, M., Willard, J.E., Grayburn, P.A. Circulation (1990)
- Efficacy of bucindolol in systemic hypertension. Kimura, S., DeQuattro, V., Edmiston, W.A., Loo, R., Thien, S., Rigonan, K., Deitchman, D., Foti, A. Am. J. Cardiol. (1987)
- The incomplete bucindolol evaluation in acute myocardial infarction Trial (BEAT). Torp-Pedersen, C., Køber, L., Ball, S., Hall, A., Brendorp, B., Ottesen, M., Berning, J., Jensen, G., Hampton, J., Zilles, P., Eberle, S., Carlsen, J. Eur. J. Heart Fail. (2002)
- A comparison of single doses of bucindolol and oxprenolol in hypertensive patients. Webster, J., Petrie, J.C., Robb, O.J., Jamieson, M., Verschueren, J. British journal of clinical pharmacology. (1985)
- Bucindolol, a beta-adrenoceptor blocker with vasodilatory action: its effect in systemic hypertension. Rotmensch, H.H., Rocci, M.L., Vlasses, P.H., Swanson, B.N., Fedder, I.L., Soyka, L., Ferguson, R.K. Am. J. Cardiol. (1984)
- A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure. Liggett, S.B., Mialet-Perez, J., Thaneemit-Chen, S., Weber, S.A., Greene, S.M., Hodne, D., Nelson, B., Morrison, J., Domanski, M.J., Wagoner, L.E., Abraham, W.T., Anderson, J.L., Carlquist, J.F., Krause-Steinrauf, H.J., Lazzeroni, L.C., Port, J.D., Lavori, P.W., Bristow, M.R. Proc. Natl. Acad. Sci. U.S.A. (2006)
- Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators. Bristow, M.R., O'Connell, J.B., Gilbert, E.M., French, W.J., Leatherman, G., Kantrowitz, N.E., Orie, J., Smucker, M.L., Marshall, G., Kelly, P. Circulation (1994)
- Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy. Woodley, S.L., Gilbert, E.M., Anderson, J.L., O'Connell, J.B., Deitchman, D., Yanowitz, F.G., Mealey, P.C., Volkman, K., Renlund, D.G., Menlove, R. Circulation (1991)
- Hemodynamic and energetic comparison of bucindolol and metoprolol for the treatment of congestive heart failure. Heesch, C.M., Marcoux, L., Hatfield, B., Eichhorn, E.J. Am. J. Cardiol. (1995)
- Effects of bucindolol on neurohormonal activation in congestive heart failure. Eichhorn, E.J., McGhie, A.L., Bedotto, J.B., Corbett, J.R., Malloy, C.R., Hatfield, B.A., Deitchman, D., Willard, J.E., Grayburn, P.A. Am. J. Cardiol. (1991)
- Evaluation of intrinsic sympathomimetic activity of bucindolol and carvedilol in rat heart. Willette, R.N., Mitchell, M.P., Ohlstein, E.H., Lukas, M.A., Ruffolo, R.R. Pharmacology (1998)
- Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo. Gilbert, E.M., Anderson, J.L., Deitchman, D., Yanowitz, F.G., O'Connell, J.B., Renlund, D.G., Bartholomew, M., Mealey, P.C., Larrabee, P., Bristow, M.R. Am. J. Med. (1990)
- Cardiac adrenergic receptor effects of carvedilol. Yoshikawa, T., Port, J.D., Asano, K., Chidiak, P., Bouvier, M., Dutcher, D., Roden, R.L., Minobe, W., Tremmel, K.D., Bristow, M.R. Eur. Heart J. (1996)
- Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers. O'Connor, P.C., Finch, M.J., Harron, D.W., Meredith, P.A., McDevitt, D.G., Shanks, R.G. British journal of clinical pharmacology. (1985)
- Bucindolol exerts agonistic activity on the propranolol-insensitive state of beta1-adrenoceptors in human myocardium. Bundkirchen, A., Brixius, K., Bölck, B., Schwinger, R.H. J. Pharmacol. Exp. Ther. (2002)
- Pharmacology of bucindolol in isolated canine vascular smooth muscle. Rimele, T.J., Aarhus, L.L., Lorenz, R.R., Rooke, T.W., Vanhoutte, P.M. J. Pharmacol. Exp. Ther. (1984)
- Different intrinsic activities of bucindolol, carvedilol and metoprolol in human failing myocardium. Maack, C., Cremers, B., Flesch, M., Höper, A., Südkamp, M., Böhm, M. Br. J. Pharmacol. (2000)
- In vitro and in vivo characterization of intrinsic sympathomimetic activity in normal and heart failure rats. Willette, R.N., Aiyar, N., Yue, T.L., Mitchell, M.P., Disa, J., Storer, B.L., Naselsky, D.P., Stadel, J.M., Ohlstein, E.H., Ruffolo, R.R. J. Pharmacol. Exp. Ther. (1999)
- Vasodilating beta-adrenoceptor blocking drugs do not redistribute myocardial flow during acute coronary ligation in dogs. Berdeaux, A., Bonhenry, C., Giudicelli, J.F. Eur. J. Pharmacol. (1985)
- Partial agonist activity of bucindolol is dependent on the activation state of the human beta1-adrenergic receptor. Maack, C., Böhm, M., Vlaskin, L., Dabew, E., Lorenz, K., Schäfers, H.J., Lohse, M.J., Engelhardt, S. Circulation (2003)
- Interaction of the beta adrenergic receptor antagonist bucindolol with serotonergic receptors. Watts, S.W., Fink, G.D., Silver, P.J., Cushing, D.J. J. Cardiovasc. Pharmacol. (2000)
- Hemodynamic properties of bucindolol, a beta-adrenoreceptor blocking drug with vasodilator activity. Bett, N., Dryburgh, L., Boyle, C., Hawley, C. Am. J. Cardiol. (1986)
- Bucindolol, a beta blocker, decreased ventricular fibrillation and maintained mechanical function in a pig model of acute myocardial ischemia. Muller, C.A., Opie, L.H., Pineda, C.A., Peisach, M. Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy. (1992)
- Importance of a history of hypertension for the prognosis after acute myocardial infarction--for the Bucindolol Evaluation in Acute myocardial infarction Trial (BEAT) study group. Ali, I., Akman, D., Bruun, N.E., Køber, L., Brendorp, B., Ottesen, M., Møller, J., Torp-Pedersen, C. Clinical cardiology. (2004)
- Studies on the vasodilator actions of bucindolol in the rat. Marwood, J.F., Stokes, G.S. Clin. Exp. Pharmacol. Physiol. (1986)